Latest Market News

Optiscan Imaging has begun commercial sales of its InSpecta™ microscopic imaging device in the US veterinary sector following FDA clearance, marking its first clinical device launch and a strategic expansion into a $15.87 billion market.

Venari Metals has agreed to sell its Georgina Basin IOCG Project in the Northern Territory to UK-listed Alien Minerals, marking a strategic shift towards its lithium and critical metals operations in Nevada. The deal includes cash, equity, and a technical services agreement, but will trigger a significant accounting loss.

Booster Wines Limited has proposed exiting its Hawke’s Bay vineyard and winery leases from the Private Land and Property Portfolio, offering a discounted convertible debt payment amid falling grape demand.

A significant shareholder bloc opposing Floorscape's acquisition has forced Bremworth to abandon its Scheme of Arrangement, leaving the flooring manufacturer to pursue standalone growth amid tough market conditions.

The a2 Milk Company faced significant supply chain disruptions in its China infant formula segment during late FY26, causing a 14% sales decline in that category. Despite this, overall revenue rose 12% on FY25, supported by strong performances in other product lines and improved margins.

Summerset Group maintained stable new sales in Q2 2026 with a notable 26% jump in resales, while prudently reducing its New Zealand build rate in response to economic uncertainty.

Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.

PainChek announces the immediate departure of CEO Philip Daffas, with COO Andy Hoggan stepping in as interim leader amid a strategic pivot to boost US market growth following FDA clearance.

Atomos Limited has trimmed its FY26 sales guidance to approximately $40 million due to softer end-consumer demand and delayed product shipments, while forecasting EBITDA between $2.5 million and $3.5 million supported by improved margins.

Compumedics reported a record $60.3 million in FY26 revenue, driven by an 18% year-on-year increase and a 70% jump in SaaS recurring revenues from Somfit and Nexus 360. The company resolved supply chain disruptions and targets faster EBITDA growth in FY27.

Stakk Limited is set to become a global powerhouse in AI-driven Digital Trust infrastructure following its US$63 million acquisition of ParaScript, a leader in AI-powered document intelligence and fraud detection. The deal significantly boosts Stakk's scale, technology, and recurring revenue base, underpinning a robust growth trajectory.

ReNerve Limited has secured regulatory approval to market its flagship NervAlign Nerve Cuff in Indonesia, marking a major step in its Asia-Pacific expansion and unlocking access to one of the region’s largest nerve repair markets.